Bengaluru-based diagnostics and healthcare platform Orange Health Labs has raised $12 million in a funding round led by the Amazon Smbhav Venture Fund.
The round saw participation from existing investors, including Accel, General Catalyst, Bertelsmann India Investments, and Y Combinator. This funding brings the company’s total capital raised to $47 million, following its Series B round of $25 million in June 2022. Shortly after that round, Orange Health launched its first employee stock option plan and equity buyback program worth $1 million.
The newly raised funds will be used to expand the company’s product offerings, strengthen its team, and drive innovation in the diagnostics sector.
Scaling Diagnostics Innovation
Founded in December 2020 by Dhruv Gupta and Tarun Bhambra, Orange Health specializes in on-demand diagnostics, offering at-home sample collection services across Bengaluru, Gurugram, Delhi, Noida, and Ghaziabad. The company has served over 1 million customers and operates six labs, partnering with over 1,000 clinics.
Orange Health claims to have achieved 3x growth in the past two years, is on track for 100% growth this year and has reached a Rs 100-crore annual revenue run rate. Notably, the company has achieved profitability in Bengaluru.
Amazon’s Strategic Backing
This investment underscores Amazon Smbhav Venture Fund’s focus on fostering Indian startups across diverse sectors. Launched in April 2021 with a corpus of $250 million, the fund has backed companies such as The Good Glamm Group, Cashify, Fitterfly, and Smallcase, alongside its first investment in Gurugram-based MSME-focused fintech startup M1xchange.
As Orange Health continues to innovate and scale its operations, this funding marks a significant milestone in its journey to revolutionize diagnostics in India.
